Abstract
Turner syndrome (TS) is the most common chromosomal abnormality in females, affecting up to 1/2000 live female births. TS is associated with partial or complete loss of the second X-chromosome in phenotypic females and is associated with increased morbidity and mortality. There are many challenges in providing optimal care for the adult TS women. This review highlights uncertainties that remain in hormone replacement therapy, bone health and cardiovascular optimization and discusses current management recommendations based on the recently published international guidelines and the experience at the TS clinic at Monash Health.
| Original language | English |
|---|---|
| Pages (from-to) | 428-436 |
| Number of pages | 9 |
| Journal | Climacteric |
| Volume | 21 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 3 Sep 2018 |
Keywords
- co-morbidity
- hormone replacement therapy
- premature ovarian insufficiency
- screening
- Turner syndrome
Cite this
}
Care of the adult woman with Turner syndrome. / Shah, S.; Nguyen, H. H.; Vincent, A. J.
In: Climacteric, Vol. 21, No. 5, 03.09.2018, p. 428-436.Research output: Contribution to journal › Review Article › Other › peer-review
TY - JOUR
T1 - Care of the adult woman with Turner syndrome
AU - Shah, S.
AU - Nguyen, H. H.
AU - Vincent, A. J.
PY - 2018/9/3
Y1 - 2018/9/3
N2 - Turner syndrome (TS) is the most common chromosomal abnormality in females, affecting up to 1/2000 live female births. TS is associated with partial or complete loss of the second X-chromosome in phenotypic females and is associated with increased morbidity and mortality. There are many challenges in providing optimal care for the adult TS women. This review highlights uncertainties that remain in hormone replacement therapy, bone health and cardiovascular optimization and discusses current management recommendations based on the recently published international guidelines and the experience at the TS clinic at Monash Health.
AB - Turner syndrome (TS) is the most common chromosomal abnormality in females, affecting up to 1/2000 live female births. TS is associated with partial or complete loss of the second X-chromosome in phenotypic females and is associated with increased morbidity and mortality. There are many challenges in providing optimal care for the adult TS women. This review highlights uncertainties that remain in hormone replacement therapy, bone health and cardiovascular optimization and discusses current management recommendations based on the recently published international guidelines and the experience at the TS clinic at Monash Health.
KW - co-morbidity
KW - hormone replacement therapy
KW - premature ovarian insufficiency
KW - screening
KW - Turner syndrome
UR - http://www.scopus.com/inward/record.url?scp=85054186631&partnerID=8YFLogxK
U2 - 10.1080/13697137.2018.1476969
DO - 10.1080/13697137.2018.1476969
M3 - Review Article
VL - 21
SP - 428
EP - 436
JO - Climacteric
JF - Climacteric
SN - 1369-7137
IS - 5
ER -